Claude Nicaise - Jun 24, 2024 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Role
Director
Signature
/s/ Daniel Porco, Attorney-in-Fact
Stock symbol
GANX
Transactions as of
Jun 24, 2024
Transactions value $
$0
Form type
4
Date filed
6/26/2024, 09:30 PM
Previous filing
May 13, 2024
Next filing
Mar 11, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GANX Stock Option (right to buy) Award $0 +15K $0.00 15K Jun 24, 2024 Common Stock 15K $1.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 12 equal monthly installments commencing on July 24, 2024, subject to the Reporting Person's continuous service through the applicable vesting date.